Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
about
The prion hypothesis in Parkinson's disease: Braak to the futureThe synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementiaTRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodiesUpregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophagesp25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophyPropagation of prions causing synucleinopathies in cultured cellsEvidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismMultiple system atrophy: a clinical and neuropathological perspectiveAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyEffects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's diseaseAntibodies against alpha-synuclein reduce oligomerization in living cellsMultiple system atrophy: clinicopathological characteristics in Japanese patients.Widespread alterations of alpha-synuclein in multiple system atrophyNeuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation.Biochemical characterization of the core structure of alpha-synuclein filaments.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseasesFilamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Alpha-synuclein in Lewy body disease and Alzheimer's disease.Multiple system atrophy: a sporadic synucleinopathy.Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.The oligodendroglia cytoskeleton in health and disease.Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms.Neuropathology of synuclein aggregates.Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.Late-onset neurodegenerative diseases--the role of protein insolubility.Clinicopathological studies on diffuse Lewy body disease.Organization and functional roles of the cytoskeleton in oligodendrocytes.The neuropathology, pathophysiology and genetics of multiple system atrophy.Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.Parkinson's disease and other alpha-synucleinopathies.SHC2 gene copy number in multiple system atrophy (MSA)Dysautonomia in Parkinson diseaseThe cellular pathology of Parkinson's disease.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesLow CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathyFAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophyProgression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding.Modelling progressive autonomic failure in MSA: where are we now?
P2860
Q22001062-0B39E83D-B1A8-4289-88CD-BEE4C5E5011BQ22252705-009DD75C-70DD-49DE-83EC-ED82316F67A3Q24296382-FA756FB3-5F79-4384-82B8-03AEE3D383B4Q24314013-98614674-B8A6-4E42-BFAB-4BCB8CA86F1AQ24682056-15F916BB-4ADA-4EC3-B465-E9D7C002926CQ26269822-E45EF41B-CF5D-42E2-B0AE-ADA99C909731Q26782028-441AC9BC-5511-4A04-B0C6-9F3D0B8D5562Q26829838-443E808A-35D7-4A46-BF2A-11BE0BFF08D2Q28395248-0DFC8B2C-D255-470D-96FF-FD67C24CF18AQ28610102-36A117BD-2D7A-4574-A500-13D8F949AFAFQ28743313-4D531D04-F331-40DF-9ED6-46072227E613Q30234494-5003FB0D-270F-4473-B606-535944D56168Q30444927-1DF793FF-4359-4656-94C2-0EAA88F3DE95Q30817400-056B90C2-06BA-4DB3-8676-A55F28B0A718Q30827075-72A7DE14-7E16-463D-8D2E-46951F0A0DB5Q33470625-8A41C12E-9B68-492C-9876-7C2A9EAAE37AQ33613123-BE183D33-7455-4420-BEF5-FA5FB9897FCAQ33703950-9924D592-BE54-4B6C-A3C5-FE1A55658366Q33750063-FCA3E368-7F70-4B3B-9E6C-856C0A9CC23EQ33750069-249AA974-2077-4FFA-9C14-B25BEB47B79DQ33805560-2A2FE187-C40D-4F5E-9F3F-9497236CBFD1Q33829490-4A73C7A8-308A-4543-AE5A-A749FA73799FQ33868205-832AB8E6-842C-41B0-8A09-F6A2DF91D2BBQ33957376-D9EC78C6-4BAF-47A5-B507-FAF4FBDF8ECFQ33958289-EE364773-D868-4AD6-A83A-501CCD72298FQ33989372-01519B53-6242-4B7E-BBD5-06E93B968C71Q33997776-F179D09C-7DFC-4BA1-9D22-B5F1C370E839Q34199602-46CAB24A-247A-498D-BFFF-2E807DA18ED0Q34231585-C2EB5EDA-11BA-4088-84E9-EF165CD12E12Q34233323-1AE40BA9-F6AA-4ACF-8DA2-67577CFCC992Q34270992-20FBE632-E922-434A-9569-52E50E31E157Q34381056-08D94ACA-DEE8-4570-B818-94D719B8DE1AQ34463831-737F061A-ACCB-4B30-9119-26E1DEAEC650Q34523836-9C6AF47E-7E01-478A-A883-8EABB6F94FA8Q34538330-643256BA-42E9-478B-9049-E6634C7D3DF4Q34544824-C4B48C4F-502C-4D45-B40F-985E8A16D18DQ34571668-ADEF0708-69D9-4FF4-9962-22E88A262AFCQ34574023-6E08029C-B3DE-4653-8823-38D45EF849B5Q34590797-E706652D-3AEA-4F3D-B618-D98540FE0DD5Q34626244-21BE4C34-525B-4500-A834-0423603F21A2
P2860
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@en
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@nl
type
label
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@en
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@nl
altLabel
α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
@en
prefLabel
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@en
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@nl
P2093
P1433
P1476
Alpha-synuclein immunoreactivi ...... ns in multiple system atrophy.
@en
P2093
H Takahashi
K Wakabayashi
M Yoshimoto
P304
P356
10.1016/S0304-3940(98)00407-8
P407
P577
1998-06-01T00:00:00Z